Use of abciximab-Modified Thrombelastography in Patients Undergoing Cardiac Surgery
- 1 September 1999
- journal article
- Published by Wolters Kluwer Health in Anesthesia & Analgesia
- Vol. 89 (3) , 580
- https://doi.org/10.1213/00000539-199909000-00007
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- ACCURACY OF NATIVE AND ACTIVATED THROMBELASTOGRAPHY FOR ASSESSMENT OF PLASMA FIBRINOGEN LEVELSAnesthesiology, 1998
- Monitoring platelet glycoprotein IIb/IIIa—fibrin interaction with tissue factor—activated thromboelastographyJournal of Laboratory and Clinical Medicine, 1997
- A452 CAN THROMBOELASTOGRAPHY ESTIMATE PLASMA FIBRINOGEN LEVELAnesthesiology, 1997
- A Modified Thromboelastographic Method for Monitoring c7E3 Fab in Heparinized PatientsAnesthesia & Analgesia, 1997
- Shear-Induced Platelet Aggregation Is Inhibited by In Vivo Infusion of an Anti–Glycoprotein IIb/IIIa Antibody Fragment, c7E3 Fab, in Patients Undergoing Coronary AngioplastyCirculation, 1995
- Aprotinin preserves hemostasis in aspirin-treated patients undergoing cardiopulmonary bypassThe Annals of Thoracic Surgery, 1994
- Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assayJournal of Cardiothoracic and Vascular Anesthesia, 1994
- Reduction of heparin binding to and inhibition of platelets by aprotininThe Annals of Thoracic Surgery, 1993
- Platelet adhesion to fibrin(ogen)Blood Coagulation & Fibrinolysis, 1993
- Blutgerinnungsstudien mit der Thrombelastographie, einem neuen UntersuchungsverfahrenJournal of Molecular Medicine, 1948